ZOPICLONE, 98.5% en es it fr

ZOPICLONE, 98.5% Brand names, ZOPICLONE, 98.5% Analogs

ZOPICLONE, 98.5% Brand Names Mixture

  • No information avaliable

ZOPICLONE, 98.5% Chemical_Formula

C17H17ClN6O3

ZOPICLONE, 98.5% RX_link

No information avaliable

ZOPICLONE, 98.5% fda sheet

ZOPICLONE, 98.5% msds (material safety sheet)

ZOPICLONE, 98.5% Synthesis Reference

No information avaliable

ZOPICLONE, 98.5% Molecular Weight

388.808 g/mol

ZOPICLONE, 98.5% Melting Point

178 oC

ZOPICLONE, 98.5% H2O Solubility

No information avaliable

ZOPICLONE, 98.5% State

Solid

ZOPICLONE, 98.5% LogP

-0.88

ZOPICLONE, 98.5% Dosage Forms

Tablet

ZOPICLONE, 98.5% Indication

For the short-term treatment of insomnia.

ZOPICLONE, 98.5% Pharmacology

Zopiclone is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class and is indicated for the short-term treatment of insomnia. While Zopiclone is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABABZ) receptor complex. Subunit modulation of the GABABZ receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models. Zopiclone binds selectively to the brain alpha subunit of the GABA A omega-1 receptor.

ZOPICLONE, 98.5% Absorption

No information avaliable

ZOPICLONE, 98.5% side effects and Toxicity

No information avaliable

ZOPICLONE, 98.5% Patient Information

No information avaliable

ZOPICLONE, 98.5% Organisms Affected

Humans and other mammals